Underutilization of medications to treat opioid use disorder: What role does stigma play?
Subst Abus
; 40(4): 459-465, 2019.
Article
em En
| MEDLINE
| ID: mdl-31550201
ABSTRACT
There is consensus in the scientific literature that the opioid agonist medications methadone and buprenorphine are the most effective treatments for opioid use disorder. Despite increasing opioid overdose deaths in the United States, these medications remain substantially underutilized. For no other medical conditions for which an effective treatment exists is that treatment used so infrequently. In this commentary, we discuss the potential role of stigma in the underutilization of these opioid agonist medications for addiction treatment. We outline stigma toward medications for addiction treatment and suggest that structural and policy barriers to methadone and buprenorphine may contribute to this stigma. We offer pragmatic public health solutions to reduce stigma and expand access to these effective treatments.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Aceitação pelo Paciente de Cuidados de Saúde
/
Tratamento de Substituição de Opiáceos
/
Estigma Social
/
Mau Uso de Serviços de Saúde
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Subst Abus
Assunto da revista:
TRANSTORNOS RELACIONADOS COM SUBSTANCIAS
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Estados Unidos